CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 6, Issue 9, Pages e1338230
Publisher
Informa UK Limited
Online
2017-07-24
DOI
10.1080/2162402x.2017.1338230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
- (2016) Marie Boutet et al. CANCER RESEARCH
- CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
- (2016) Hagma H. Workel et al. EUROPEAN JOURNAL OF CANCER
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
- (2016) Fenne L. Komdeur et al. Oncotarget
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
- (2015) I. C. van Gool et al. CLINICAL CANCER RESEARCH
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome
- (2015) Arko Gorter et al. Journal of Translational Medicine
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Endocervical adenocarcinoma: selected diagnostic challenges
- (2015) Brigitte M Ronnett MODERN PATHOLOGY
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
- (2015) J. R. Webb et al. Cancer Immunology Research
- A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development
- (2015) Oana Draghiciu et al. OncoImmunology
- Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
- (2015) Simona Partlová et al. OncoImmunology
- Regression of Human Papillomavirus Intraepithelial Lesions Is Induced by MVA E2 Therapeutic Vaccine
- (2014) Ricardo Rosales et al. HUMAN GENE THERAPY
- Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
- (2014) M. Mokrani et al. JOURNAL OF IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal Lesions
- (2014) L. Maldonado et al. Science Translational Medicine
- Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients
- (2014) Kei Kawana et al. VACCINE
- Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
- (2014) Tae Jin Kim et al. Nature Communications
- The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
- (2013) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
- (2013) J. R. Webb et al. CLINICAL CANCER RESEARCH
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
- (2013) Laura K Mackay et al. NATURE IMMUNOLOGY
- A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
- (2012) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer
- (2012) Toshiyuki Sasagawa et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Control of the development of CD8αα+ intestinal intraepithelial lymphocytes by TGF-β
- (2011) Joanne E Konkel et al. NATURE IMMUNOLOGY
- Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
- (2009) M. G. Noordhuis et al. CLINICAL CANCER RESEARCH
- The Prognostic Value of TRAIL and its Death Receptors in Cervical Cancer
- (2009) John H. Maduro et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Transforming Growth Factor 1 Promotes Chromosomal Instability in Human Papillomavirus 16 E6E7-Infected Cervical Epithelial Cells
- (2008) W. Deng et al. CANCER RESEARCH
- Transforming Growth Factor : Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?
- (2008) L. Yang et al. CANCER RESEARCH
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
- (2008) C. L. Trimble et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now